Ajanta Pharma Limited is a specialty pharmaceutical formulation company that focuses on developing, manufacturing, and marketing finished dosages. With its subsidiaries, the company caters to various therapeutic segments including anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory, general health products, dermatology, ophthalmology, and pain management areas. In addition to this, Ajanta Pharma also offers a range of multivitamins, antibiotics, eye drops, cough syrups, and more. The company operates in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies such as armed forces, government hospitals, canteens, and stores departments. Established in 1973, Ajanta Pharma Limited is headquartered in Mumbai, India.
Ajanta Pharma Limited
- 2,795.50 -100.45(-3.47%) 2,800.25 -88.10(-3.05%)
Live Ajanta Pharma Limited Share Price Chart
Ajanta Pharma Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 2,785.00 2,791.00 | 2,905.95 2908.85 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 1,998.35 (13-Mar-2024) 2,003.55 (13-Mar-2024) | 3,485.00 (12-Sep-2024) 3,485.75 (12-Sep-2024) |
- Open
- 2,905.95 2,899.00
- Previous Close
- 2,895.95 2,888.35
- Volume
- 0.39
- Total Traded value
- 11.05 (Lakhs)
- Upper circuit
- 3,475.10 2,669.70
- Lower circuit
- 2,316.80 1,779.80
Ajanta Pharma Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 59 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 2,796.55 | 59.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 59 |
Ajanta Pharma Limited Share Fundamentals
| Market Cap: | 349.19 Cr |
| PE Ratio (TTM): | 40.96 |
| PB Ratio: | 9.91 |
| Industry P/E: | 41.34 |
| Debt to Equity: | - |
| ROE: | 24.19 |
| EPS (TTM): | 68.36 |
| Book Value: | 258.95 |
| Face Value: | 2.00 |
Ajanta Pharma Limited Stock Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 945.18 Cr | 1,014.58 Cr | 848.86 Cr | 874.89 Cr | 837.23 Cr |
| Profit | 212.36 Cr | 212.04 Cr | 117.21 Cr | 123.96 Cr | 167.18 Cr |
| Expense | 706.84 Cr | 770.67 Cr | 737.65 Cr | 750.45 Cr | 709.01 Cr |
| Comprehensive income | 211.95 Cr | 211.42 Cr | 115.82 Cr | 123.67 Cr | 166.49 Cr |
| EPS | 16.85 | 16.84 | 9.15 | 9.67 | 13.05 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Ajanta Pharma Limited | May, 2000 Jun, 2000 | Pharmaceuticals Pharmaceuticals | AJANTPHARM AJANTPHARM |
Ajanta Pharma Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Apr, 2023 Mar, 2023 Dec, 2022
Ajanta Pharma Limited Share FAQ's
What is the range of today's stock performance for Ajanta Pharma Limited?
Today's stock performance witnessed a fluctuation from a minimum of 2,785.00 on the NSE (National Stock Exchange) to a maximum of 2,905.95. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 2,791.00 to a high of 2,908.85.
What are the 52-week low and high values for Ajanta Pharma Limited?
The stock's performance over the past 52 weeks reveals a low of 1,998.35 (occurred on 13-Mar-2024) and a high of 3,485.00 (achieved on 12-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 2,003.55 (on 13-Mar-2024), and the 52-week high is 3,485.75 (on 12-Sep-2024).
What was the opening and previous closing prices for Ajanta Pharma Limited?
The stock's performance over the past 52 weeks reveals a low of 1,998.35 (occurred on 13-Mar-2024) and a high of 3,485.00 (achieved on 12-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 2,003.55 (on 13-Mar-2024), and the 52-week high is 3,485.75 (on 12-Sep-2024).
What is the total volume and traded value for Ajanta Pharma Limited for the day?
The total volume is 0, and the total traded value is 11.05 ( Lakhs).
What are the upper and lower circuit limits for Ajanta Pharma Limited?
The upper circuit limit is 3,475.10, and the lower circuit limit is 2,316.80.
What is the market cap and PE ratio for Ajanta Pharma Limited?
The market cap is 349.19 Cr, and the PE ratio (TTM) is 41.34.
What is the PB ratio, industry P/E, and debt to equity ratio for Ajanta Pharma Limited?
The PB ratio is 10.80, industry P/E is 41.34 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Ajanta Pharma Limited?
ROE is 24.19, EPS is 68.36, book value is 258.95
What are the revenue and profit figures for the latest quarter and previous quarters for Ajanta Pharma Limited?
In Sep 2023, Revenue is 9451800000.00, and Profit is 2123600000.00. In Jun 2023, Revenue is 10145800000.00, and Profit is 2120400000.00.
When was Ajanta Pharma Limited listed, and what industry does it belong to?
The company, Ajanta Pharma Limited, was listed in May 2000 and belongs to the Pharmaceuticals industry. Its NSE symbol is AJANTPHARM.
What is the current shareholding pattern of the Ajanta Pharma Limited?
As of latest available update, promoters hold 66.21%, the public holds 33.79%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 36
- Threads
- 197
